How do different cancer subtypes arise? Do they originate from distinct cells, or from a single multipotent cell capable of ...
How do different cancer subtypes arise? Do they originate from distinct cells, or from a single multipotent cell capable of ...
The classical drug discovery paradigm begins with a known molecular target: a protein whose modulation is expected to reverse ...
Researchers found that smaller cancer cells with doubled DNA often behaved more aggressively than larger ones.
Cancer cell DNA doubling — when cells accidentally duplicate all chromosomes without dividing — now has a new risk factor: cell size. A Virginia Tech study in PNAS found smaller tetraploid cancer ...
Significant reductions seen in non-small cell lung cancer, breast cancer, colorectal cancer, and hepatocellular carcinoma.
Utah State University scientists recently unveiled a new type of CRISPR biotechnology with the ability to selectively target ...
CAR T-cell therapy has been hugely successful in treating certain types of tumours, and stiffening up cancer cells beforehand could make it even more effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results